Russian cancer centers to receive Elekta Axesse

TriMed Staff | | Health Imaging | Practice Management
The Meshalkin Research Institute of Circulation Pathology and the Hertzen Moscow Oncology Research Institute have purchased Elekta Axesse systems.

Elekta Axesse will be delivered with Elekta VMAT (Volumetric Modulated Arc Therapy), which enables faster treatment time and more accurate targeting of the dose. Hertzen will be the first clinic in Russia to provide this technology to patients, according to Elekta.

The advanced technology is delivered with Mosaiq, the integrated suite of EMR software in oncology, the company said.

TriMed Staff

Related Content

Do large language models help or hinder workflows related to radiology reports?
Hospital creates 'virtual reality technologist' role to support patients during interventional procedures
Telehealth visits not to blame for uptick in imaging orders, study shows
Up to half of medical organizations either already using or preparing to implement AI
Warning: Sidelined reactor could trigger medical isotope shortage
Malpractice watchers: Radiologists, imaging societies should bone up on the ‘science of visual perception’

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.